UVI 3003

UVI 3003 is an antagonist of Retinoid Receptors used in studies of Hormone Signaling. In practice, this places the compound in experiments that measure ligand-dependent transcriptional programs and endocrine regulation in developmental biology, endocrinology, and metabolism models.

By blocking Retinoid Receptors, UVI 3003 can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In developmental biology, endocrinology, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Retinoid Receptors
• Pathway perturbation studies connected to Hormone Signaling
• Receptor-blockade and ligand-competition studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, UVI 3003 is appropriate when a defined chemical perturbant is needed to connect Retinoid Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in developmental biology, endocrinology, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.